.png?#)
FDA approves UroGen's bladder cancer hydrogel after negative adcomm vote
The FDA on Thursday approved UroGen’s application for its bladder cancer drug, despite a negative vote from an advisory committee last month. The drug, which UroGen will brand as Zusduri, is ...
The FDA on Thursday approved UroGen’s application for its bladder cancer drug, despite a negative vote from an advisory committee last month.
The drug, which UroGen will brand as Zusduri, is ...
